Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

UC Davis Comprehensive Cancer Center is the first in the region to offer a new groundbreaking clinical trial for bladder ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The following is a summary of “Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification of Diseases, 10th Revision [ICD-10] codes ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer offers better perioperative outcomes.

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...